Page 13 - MSC & Exosomes in autoimmune

3566 Chung et al.

plantation time, and cells dosage. Transplantation route REFERENCES
and time are closely related to the blood–brain barrier Bederson JB, Pitts SJ, Germano SM, Nishimura MC, Davis RL, Bart-
(BBB), which is unique a feature of the brain. Intrave- kowski HM. 1986. Evaluation of 2,3,5-triphenyltetrazolium chloride as
nously delivered cells are unlikely to migrate from the a stain for detection and quantification of experimental cerebral infarc-
vascular system into central nervous system (CNS) tissue tion in rats. Stroke 17:1304–1308.
under normal conditions, because they may not pass Bicknese AR, Goodwin HS, Quinn CO, Henderson VC, Chien SN,
through the BBB between the vascular system and the Wall DA. 2002. Human umbilical cord blood cells can be induced to
central nervous system (Iihoshi et al., 2004). BBB per- express markers for neurons and glia. Cell Transplant 11:262–264.
meability begins to increase at 3 hr of reperfusion after Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. 2004. Central
MCAO, reaches a maximum at 48 hr, and decreases nervous system entry of peripherally injected umbilical cord blood cells
from 4 days after stroke (Hatashita and Hof, 1990). is not required for neuroprotection in stroke. Stroke 35:2385–2389.
Chen et al. (2001b) reported functional improvement Chen J, Li Y, Wang L, Zhang A, Lu D, Lu M, Chopp M. 2001a. Ther-
apeutic benefit of intravenous administration of bone marrow stromal
from delayed stem cell treatment of brain ischemia in
cells after cerebral ischemia in rats. Stroke 32:1005–1011.
rodents (transplanted by an intravenous route 7 days after Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos
the ischemia insult), but the dose of MSCs was high. J, Chopp M. 2001b. Intravenous administration of human umbilical
In the present study, an intraarterial injection route cord blood reduces behavioral deficits after stroke in rats. Stroke
using the basilar artery after 1 day of ischemic insult was 32:2682–2688.
selected. Many stem cell studies have been done in Corbett RJ, Purdy PD, Laptook AR, Chaney C, Garcia D. 1999. Non-
rodents with intravenous or intrastriatal injection of stem invasive measurement of brain temperature after stroke. AJNR Am J
cells. However, local intracerebral injection induces local Neuroradiol 20:1851–1857.
brain damage (Gage et al., 1995; Chen et al., 2001a). In- Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO,
travenous injection is a simple approach for cell therapy Peterson DA, Suhr ST, Ray J. 1995. Survival and differentiation of
but requires a high dose of stem cells to achieve thera- adult neuronal progenitor cells transplanted to the adult brain. Proc
peutic effects. Even in a rodent model, at least 1 3 10 6 Natl Acad Sci U S A 92:11879–11883.
cells are needed to manifest behavioral improvement. Garcia GH. 1992. The evolution of brain infarcts: a review. J Neuropa-
This would translate for humans into using cells derived thol Exp Neurol 51:387–393.
7
from at least 20 cords for just one dose of 10 cells, and Garosi L, McConnell JF, Platt SR, Barone G, Baron JC, Lahunta D,
expansion of cells before the injection is inhibited in the Schatzberg SJ. 2006. Clinical and topographic magnetic resonance char-
acteristic of suspected brain infarction in 40 dogs. J Vet Intern Med
clinical situation in many countries (Chen et al., 2001a; 20:311–321.
Vendrame et al., 2004). Therefore, intraarterial injection Hatashita S, Hoff JT. 1990. Brain edema and cerebrovascular permeability
of the targeted organ may be a more effective approach during cerebral ischemia in rats. Stroke 21:582–588.
for stem cell therapy. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK,
In the present study, intraarterially delivered Han H, Kim H. 2005. In vitro differentiation of human umbilical cord
HUCB-derived MSCs successfully reached the cerebral blood-derived mesenchymal stem cells into hepatocyte-like cells. Bio-
ischemia lesion area 1 day after the cerebral ischemia chem Biophys Res Commun 330:1153–1161.
insult. Transplanted cells differentiated into neurons and Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H,
astrocytes and expressed neuroprotective factors such as Kocsis JD. 2006. Intravenous infusion of immortalized human mesen-
BDNF and VEGF 4 weeks after the transplantation. chymal stem cells protects against injury in a cerebral ischemia model in
Transplanted cells showed their efficacy by reducing the adult rat. Exp Neurol 199:56–66.
Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD.
infarction lesion volume at 1 week and through earlier
2006. Intravenous administration of glial cell line-derived human mes-
recovery of neurological deficits. Neurobehavioral recov-
enchymal stem cells protects against injury in a cerebral ischemia model
ery and infarction lesion volume changes between the two in the adult rat. J Neurosci Res 83:1495–1504.
groups might have been more remarkable if greater num- Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. 2004. A thera-
bers of HUCB-derived MSCs had been injected. Infarc- peutic window for intravenous administration autologous bone marrow
tion lesions produced by the thromboembolic cerebral after cerebral ischemia in adult rats. Brain Res 29:1417–1422.
ischemia model were consistent with the MCA territory, Jeong JA, Gang EJ, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C,
but the extent of the lesion was not consistent. Animals Han H, Kim H. 2004. Rapid Neural differentiation of human cord
for the transplantation procedure had been selected ran- blood-derived mesenchymal stem cells. Neuroreport 15:1731–1734.
domly among ischemic model animals without consider- Kang EJ, Hong SH, Jeong JA, Hwang SH, Kim SW, Yang IH, Ahn C,
ing lesion volume, but the HUCBC group had greater Han H, Kim H. 2004. In vitro mesengenic potential of human umbili-
infarction lesion volumes than the control group before cal cord blood-derived mesenchymal stem cells. Biochem Biophys Res
the initiation of stem cell transplantation. In addition, only Commun 321:102–108.
small numbers of experimental dogs were used in this Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH,
study. Further study with a larger number of experimental Han H. 2005. A thirty-seven-old spinal cord injured female patient
transplanted of multipotent stem cells from human UC blood, with
dogs and a more controlled design with an increased dos- improved sensory perception and mobility, both functionally and
age of cells for an extended study period are needed to morphologically: a case study. Cytotherapy 7:368–373.
clarify the effects of intraarterially delivered HUBC- Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M,
derived MSCs through the basilar artery in a canine Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K,
thromboembolic cerebral ischemic model. Date I, Hamada H. 2005. Mesenchymal stem cells that produce neuro-

Journal of Neuroscience Research